Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lasertec Corporation (“Lasertec” or “the Company”) (OTCMKTS: LSRCF). Investors who purchased Lasertec securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether Lasertec has violated federal securities laws.
Investigation Details:
On June 5, 2024, Scorpion Capital (“Scorpion”) published an investigative report on Lasertec. Scorpion accused Lasertec of concocting a textbook accounting scheme, fraudulently inflating revenue, margins, and earnings. Scorpion also predicts that Lasertec will incur a significant impairment charge that could erase most of the Company’s earnings since the launch of its flagship ACTIS extreme ultraviolet inspection machine. On this news, Lasertec’s stock price fell $27.00 per share, or $10.33%, to close at $234.50 per share on June 5, 2024.
What’s Next?
If you are aware of any facts relating to this investigation or purchased Lasertec securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
LSRCF — Stock Performance
About Bronstein, Gewirtz & Grossman, LLC
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”